{{Rsnum
|rsid=2314398
|Chromosome=2
|position=96747751
|Orientation=plus
|GMAF=0.2603
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 52.3 | 43.1 | 4.6
| HCB | 60.0 | 24.4 | 15.6
| JPT | 65.9 | 31.8 | 2.3
| YRI | 68.3 | 30.2 | 1.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 60.0 | 24.4 | 15.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2314398
|PubMedID=18711365
|Condition=Bipolar disorder
|Gene=Intergenic
|Risk Allele=
|pValue=3.00E-006
|OR=1.17
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2314398
|Name_s=
|Gene_s=LMAN2L
|Feature=
|Evidence=PubMed ID:18711365; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder (Initial Sample Size: 1,098 cases, 1,267 controls; Replication Sample Size: 4,387 cases, 6,209 controls). This variant is associated with Bipolar disorder.
|Drugs=
|Drug Classes=
|Diseases=Bipolar Disorder
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356410
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2314398
|overall_frequency_n=23
|overall_frequency_d=128
|overall_frequency=0.179688
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto
|PMID=25124521
|Title=Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}